TNF-α inhibitors are highly effective for psoriasis and PsA but are consistently associated with ANA seroconversion, anti-dsDNA induction, drug-induced lupus, and lupus flares [10,18,21,22,23,24,25]. The gene discussed is TNF; the disease is systemic lupus erythematosus.